info@marketresearchfuture.com   đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Cell Viability Assays Companies

Cell viability assays are widely used in biological research and drug discovery to assess the health and viability of cells in culture. These assays provide valuable information about cell proliferation, apoptosis, and overall cellular health. Companies involved in the development and manufacturing of cell viability assay products typically operate in the life sciences, biotechnology, and pharmaceutical sectors

Cell Viability Assays Companies

 


Latest Cell Viability Assays Companies Update:

Thermo Fisher Scientific (US) acquired Pheno Therapeutics (US): This move strengthens Thermo Fisher's presence in the cell viability assays market by granting access to Pheno Therapeutics' expertise in high-throughput antibody screening.


Creative Biolabs (US) partners with Absea (France): This partnership expands Creative Biolabs' offerings by offering a comprehensive range of pre-clinical research services, including custom monoclonal antibody development for cell viability assays.


Promega Corporation (US) launched the CellSensor™ Green Fluorescence Live Cell Viability Assay: This new assay offers a simple and rapid method for measuring cell viability using a fluorescence microscope, making it ideal for high-throughput screening applications.


Sartorius Stedim Biotech (Germany) unveiled the IncuCyte S3 Live-Cell Analysis System: This advanced system provides real-time monitoring of cell viability and function through its imaging and analysis capabilities, enabling researchers to gain deeper insights into cell behavior.


Roche (Switzerland) introduced the xCELLigence Real-Time Cell Monitoring System: This label-free platform offers continuous monitoring of cell viability and behavior, providing researchers with a valuable tool for studying cellular responses in real-time.


List of Cell Viability Assays companies in the market

  • Thermo Fisher Scientific

  • Merck KGaA

  • Bio-Rad Laboratories

  • GE Healthcare

  • Danaher Corporation

  • Becton Dickinson & Company

  • Promega Corporation

  • Biotium

  • Abcam plc

  • Creative Bioarray


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.